Gullans Steven R. Ph.D. 4
4 · Gemphire Therapeutics Inc. · Filed Jan 30, 2018
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-29+60,000→ 60,000 totalExercise: $10.44Exp: 2028-01-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 12 equal consecutive monthly installments on the last day of each month, commencing on the grant date, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.